Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study
Patrice Chevallier(Hotel Dieu Hospital), Philippe Rousselot(Université Paris-Saclay), Marie Balsat(Hôpital Claude Huriez), Thibault Leguay, Emmanuelle Clappier(Centre National de la Recherche Scientifique), Rathana Kim(Centre National de la Recherche Scientifique), Marc Delord, Michael Doubek(Central European Institute of Technology), Stéphane Leprêtre(Normandie Université), Colombe Saillard(Institut Paoli-Calmettes), Claude Gardin(Sorbonne Université), Emmanuel Raffoux(Inserm), Anna Berceanu(Centre Hospitalier Universitaire de Besançon), Nicolas Boissel(Inserm), Thomas Cluzeau(Centre Hospitalier Universitaire de Nice), Aurélie Cabannes‐Hamy(Centre Hospitalier de Versailles), Hervé Dombret(Université Paris Cité), Ulla Wartiovaara‐Kautto(Helsinki University Hospital), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse)
Cited by 32
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k